Erica Browne to Zimbabwe
This is a "connection" page, showing publications Erica Browne has written about Zimbabwe.
Connection Strength
0.773
-
Incorporating end-users' voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe. BMC Womens Health. 2023 02 10; 23(1):58.
Score: 0.205
-
Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment. AIDS Behav. 2020 May; 24(5):1443-1451.
Score: 0.169
-
Higher Acceptability of the Monthly Dapivirine Ring Versus Daily Oral Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women in Sub-Saharan Africa in the REACH Trial. J Acquir Immune Defic Syndr. 2025 Dec 15; 100(5):415-424.
Score: 0.062
-
We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe. PLoS One. 2024; 19(8):e0308577.
Score: 0.057
-
Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial. AIDS Behav. 2024 Sep; 28(9):2990-3000.
Score: 0.056
-
Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe. AIDS Behav. 2022 Dec; 26(12):3848-3861.
Score: 0.051
-
Couples' decision making regarding the use of multipurpose prevention technology (MPT) for pregnancy and HIV prevention. AIDS Behav. 2023 Jan; 27(1):198-207.
Score: 0.049
-
Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2020 Feb; 24(2):617-628.
Score: 0.042
-
Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products. J Acquir Immune Defic Syndr. 2019 12; 82 Suppl 3:S222-S229.
Score: 0.041
-
End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019 05; 22(5):e25283.
Score: 0.040